-
公开(公告)号:US20060084625A1
公开(公告)日:2006-04-20
申请号:US11253322
申请日:2005-10-19
申请人: Toufigh Gordi , Ann Olmsted , Hsiao Lieu , Luiz Belardinelli
发明人: Toufigh Gordi , Ann Olmsted , Hsiao Lieu , Luiz Belardinelli
IPC分类号: A61K31/7076
CPC分类号: A61K31/00 , A61K9/0019 , A61K31/7076
摘要: Myocardial imaging methods that are accomplished by administering doses of a pharmaceutical composition including regadenoson—an adenosine A2A receptor agonist—to a human undergoing myocardial imaging in an amount sufficient to achieve at least a minimal increase in average coronary peak flow velocity.
摘要翻译: 通过将剂量的药物组合物(包括腺苷A 2A 2A受体激动剂)施用于经历心肌成像的人,其量足以实现平均冠状动脉的至少最小增加而实现的心肌成像方法 峰值流速。
-
公开(公告)号:US5821084A
公开(公告)日:1998-10-13
申请号:US342930
申请日:1994-11-21
CPC分类号: C12Y301/03048 , C12N9/16 , C07K2319/00
摘要: A previously undiscovered transmembrane protein tyrosine phosphatase expressed only in bone and testis, osteotesticular protein tyrosine phosphatase (OST-PTP), has been identified, cloned, sequenced, expressed and subjected to enzymatic analysis. Also, a truncated osteoblast specific form (OST) containing the OST-PTP receptor but lacking the catalytic domain was identified and characterized. Based on the unique expression pattern of OST-PTP and OST during osteogenesis, assays can be used to screen for abnormal bone growth patterns and metabolic bone diseases. Moreover, this novel protein provides a specific target for use in conventional and gene therapies directed at treatment of osteoporosis, osteopetrosis and other bone metabolic disorders.
摘要翻译: 已经鉴定,克隆,测序,表达并进行酶分析,以前未发现的跨膜蛋白酪氨酸磷酸酶仅在骨和睾丸中表达,骨形成蛋白酪氨酸磷酸酶(OST-PTP)。 此外,鉴定和表征含有OST-PTP受体但缺乏催化结构域的截短成骨细胞特异性形式(OST)。 基于OST-PTP和OST在成骨期间的独特表达模式,可以使用测定法筛选异常骨生长模式和代谢性骨疾病。 此外,这种新型蛋白提供了用于治疗骨质疏松症,骨质疏松症和其他骨代谢障碍的常规和基因疗法中的特异性靶标。
-